Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2,387 Million
(Quarterly Results - Mar 2026)
Net Profit:
383 Million
Pharmaceuticals & Biotechnology
JPY 50,735 Million (Small Cap)
8.00
NA
0.00%
0.97
38.72%
3.11






